Mass cytometry reveals immune signatures associated with cytomegalovirus (CMV) control in recipients of allogeneic haemopoietic stem cell transplant and CMV-specific T cells.
Helen Marie McGuireSimone RizzettoBarbara P WithersLeighton E ClancySelmir AvdicLauren SternEllis PatrickBarbara Fazekas de St GrothBarry SlobedmanDavid J GottliebFabio LucianiEmily BlythPublished in: Clinical & translational immunology (2020)
The clinical benefit of CMV-VST may be mediated by the recovery of an adaptive immune signature characterised by activated CD8+ T cells.